The drug is intended for adolescents and children who weigh more than 15 kg.
Erdomed is a mucolytic that, after oral administration, reduces the viscosity of bronchial secretions and promotes their elimination, improving respiration.
Erdomed is used as a secretolytic therapy in acute and chronic bronchitis, associated with impaired mucus production and transport, and for thinning of viscous mucus in acute and chronic airway disorders.
Active ingredient of erdomed
- The active substance is erdosteinum.
Erdomed comes in a blister pack of 300 mg capsules and vials.
Its excipients are: microcrystalline cellulose, povidone, magnesium stearate; the capsule, gelatin, titanium dioxide (E 171), yellow iron oxide (E172), erythrosine (E127), indigotine (E132).
- Treatment of disorders of bronchial secretion, favoring the thinning of mucus and mucopurulent secretions or expectoration.
- Acute and chronic lung disorders (exacerbations passing or stable bronchitis, acute and chronic bronchiectasis, asthma, bronchial hypersecretion)
- Acute and chronic disorders of the upper respiratory tract (rhinitis, sinusitis, pharyngitis, laryngitis, tracheitis).
Hypersecretory of lung diseases such as:
- Pulmonary emphysema.
- Chronic bronchitis in smokers.
Prophylaxis and treatment of respiratory complications after surgery:
- Pulmonary atelectasis
Mechanism of action of erdomed
The mechanism of action is as an antioxidant and glycoprotein inhibitor.
Erdomed should always be used exactly as your doctor has instructed you.
- Children weighing between 15 and 19 kg: 5 ml of oral suspension, 2 times a day.
- Children weighing between 20 and 30 kg: 5 ml of oral suspension 3 times a day.
- Children weighing more than 30 kg and adults: 10 ml of oral suspension twice a day.
Form of administration
Preparation of the suspension: add water in the powder vial to the mark marked on the vial and shake vigorously; Fill to the mark with water and shake again.
The vial should be shaken before each administration.
The usual dose of the capsule (300 mg of erdosteine), should be administered orally 2 to 3 times a day.
Side effects of erdomed
Rare cases of gastralgia, nausea and vomiting have been reported after high doses (more than 1200 mg per day).
On rare occasions, hypersensitivity reactions (skin rash, urticaria, etc.) have been reported.
Warnings and Contraindications
Erdomed should not be administered if you have hypersensitivity to erdosteine or to any of the excipients in the product, or in children weighing less than 15 kg.
Special care should be taken with the administration of erdomed in patients suffering from gastroduodenal ulcer.
In patients with severe liver or kidney involvement, it should be administered under medical supervision.
This medicine contains aspartame (E 951). For being a source of phenylalanine. It can be harmful for people with conditions such as phenylketonuria.
In patients with homocysteinuria, its use is not recommended due to the possible interaction of the metabolites with the metabolism of methionine and cysteine.
Because there are no clinical data available and it is not known whether the drug passes into breast milk, erdomed is not recommended during breastfeeding.
Although preclinical studies did not reveal embryotoxic, teratogenic, or mutagenic in the absence of clinical data, erdomed is not recommended during pregnancy.
No adverse effects that decrease the ability to drive vehicles or operate machinery have been reported.
This medicine contains sugar. If you have an intolerance to some sugars, you should consult your doctor before taking erdomed.
Each 5 ml of oral suspension contains approximately 2 grams of sugar. This should be considered in patients suffering from diabetes.
As the volume of bronchial secretions increases, Erdomed can accentuate the cough reflex. Do not take medicine that suppresses cough, as sputum will not be able to be removed.
Medications being taken, even those purchased without a prescription, should be reported to the physician.
Erdomed should not be administered with a cough suppressant because it can cause excessive accumulation of secretions due to inhibition of the cough reflex, resulting in stagnant secretions with a possible risk of bronchospasm and respiratory infections.
Erdosteine can be administered concomitantly with antibiotics such as amoxicillin, ampicillin, clarithromycin, ciprofloxacin, or erythromycin, as well as bronchodilators such as salbutamol, or theophylline.